Advancing European Research Infrastcuture on Highly Pathogenic Agents

Informacje na temat projektu

ERINHA-Advance

Identyfikator umowy o grant: 824061

DOI

10.3030/824061

Projekt został zamknięty

Data podpisania przez KE 20 Listopada 2018

Data rozpoczęcia 1 Stycznia 2019

Data zakończenia 30 Czerwca 2022

Finansowanie w ramach

• EXCELLENT SCIENCE - Research Infrastructures

Koszt całkowity

€ 3 746 804,14

Wkład UE

€ 3 746 804,14

Koordynowany przez

EUROPEAN RESEARCH INFRASTRUCTURE ON HIGHLY PATHOGENIC AGENTS
Belgium

CORDIS oferuje możliwość skorzystania z odnośników do publicznie dostępnych publikacji i rezultatów projektów realizowanych w ramach programów ramowych HORYZONT.

Odnośniki do rezultatów i publikacji związanych z poszczególnymi projektami 7PR, a także odnośniki do niektórych konkretnych kategorii wyników, takich jak zbiory danych i oprogramowanie, są dynamicznie pobierane z systemu OpenAIRE .

Rezultaty

Documents, reports (8)

Report on the activities and interest expressed from the CEE

It will also include information on actions put in place to attract CEE countries

Report on workshop with African partners

INSA Report with the description discussions and conclusions of the workshop with African partners

Report on International strategy and cooperation

It includes ERINHAs international strategy clarifying targets conditions and legal framework of international cooperation as well as information on interactions with countries and initiatives outside of Europe

ERINHA-Advance communication tools

Pack of tools for relevant ERINHA-Advance events and meetings

Users’ handbook

The document provides in userfriendly way the information on the overall services framework including the IPR Ethics quality and data information

Ethical requirements for ERINHA guidelines

It includes global ethical framework for ERINHA and specific national regulations.

ERINHA Quality management tools

It includes quality management Quality Chart audit system tools and questionnaires

Factsheet on two showcases of European countries

It includes comprehensive information of the strategies and policies develop to enable a nonBSL4 and one to be BSL4 country to become an ERINHA member

Publikacje

Peer reviewed articles (7)

A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model

Autorzy: David W. Hawman, Gustaf Ahlén, K. Sofia Appelberg, Kimberly Meade-White, Patrick W. Hanley, Dana Scott, Vanessa Monteil, Stephanie Devignot, Atsushi Okumura, Friedemann Weber, Heinz Feldmann, Matti Sällberg and Ali Mirazimi
Opublikowane w: Nature Microbiology, 2021, ISSN 2058-5276
Wydawca: Nature
DOI: 10.1038/s41564-020-00815-6

Biobanks for life sciences and personalized medicine: importance of standardization, biosafety, biosecurity, and data management

Autorzy: Heimo Müller, Georges Dagher, Martina Loibner, Cornelia Stumptner, Penelope Kungl, Kurt Zatloukal
Opublikowane w: Current Opinion in Biotechnology, Numer 65, 2020, Strona(/y) 45-51, ISSN 0958-1669
Wydawca: Elsevier BV
DOI: 10.1016/j.copbio.2019.12.004

A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection

Autorzy: Tingting Li, Hongmin Cai, Hebang Yao, Bingjie Zhou, Ning Zhang, Martje Fentener van Vlissingen, Thijs Kuiken, Wenyu Han, Corine H. GeurtsvanKessel, Yuhuan Gong, Yapei Zhao, Quan Shen, Wenming Qin, Xiao-Xu Tian, Chao Peng, Yanling Lai, Yanxing Wang, Cedric A. J. Hutter, Shu-Ming Kuo, Juan Bao, Caixuan Liu, Yifan Wang, Audrey S. Richard, Hervé Raoul, Jiaming Lan, Markus A. Seeger, Yao Cong, Barry R
Opublikowane w: Nature Communications, Numer 12/1, 2021, ISSN 2041-1723
Wydawca: Nature Publishing Group
DOI: 10.1038/s41467-021-24905-z

Limiting factors for wearing personal protective equipment (PPE) in a health care environment evaluated in a randomised study

Autorzy: Martina Loibner, Sandra Hagauer, Gerold Schwantzer, Andrea Berghold, Kurt Zatloukal
Opublikowane w: PLOS ONE, Numer 14/1, 2019, Strona(/y) e0210775, ISSN 1932-6203
Wydawca: Public Library of Science
DOI: 10.1371/journal.pone.0210775

Uncovering a conserved vulnerability site in SARS‐CoV‐2 by a human antibody

Autorzy: Tingting Li, Hongmin Cai, Yapei Zhao, Yanfang Li, Yanling Lai, Hebang Yao, Liu Daisy Liu, Zhou Sun, Martje Fentener van Vlissingen, Thijs Kuiken, Corine H GeurtsvanKessel, Ning Zhang, Bingjie Zhou, Lu Lu, Yuhuan Gong, Wenming Qin, Moumita Mondal, Bowen Duan, Shiqi Xu, Audrey S Richard, Hervé Raoul, JianFeng Chen, Chenqi Xu, Ligang Wu, Haisheng Zhou, Zhong Huang, Xuechao Zhang, Jun Li, Yanyan Wang
Opublikowane w: EMBO Molecular Medicine, 2021, ISSN 1757-4676
Wydawca: John Wiley & Sons Ltd.
DOI: 10.15252/emmm.202114544

Experience Report on Different PPE Variants used in a BSL-3 Facility for Autopsies and COVID-19-Related Research

Autorzy: Martina Loibner
Opublikowane w: Journal of Infectious Diseases & Preventive Medicine, 2021, ISSN 2329-8731
Wydawca: Longdom Group SA

Biosafety Requirements for Autopsies of Patients with COVID-19: Example of a BSL-3 Autopsy Facility Designed for Highly Pathogenic Agents

Autorzy: Loibner M.,Langner C.,Regitnig P.,Gorkiewicz G., Zatloukal K.
Opublikowane w: Pathobiology, 2020, ISSN 1015-2008
Wydawca: S. Karger AG
DOI: 10.1159/000513438